Umoja Biopharma

David Fontana, Ph.D., Chief Operating Officer and Chief Business Officer

Oct. 8 | 1:15pm | FLW Ballroom G 

Seattle, WA

(Private)

Umoja is an in vivo gene delivery immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR T cell therapies in oncology and autoimmunity.

www.Umoja-biopharma.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions